Program Policies & Procedures

Provides information about the development and potential uses of the USAUDIT alcohol screening clinical decision support that can be integrated into electronic health record systems and other health information technology to help providers identify adults who should be screened for alcohol use

Provides detailed information on a wide variety of alcohol-related policies in the United States at both State and Federal levels

Development of a taxonomy of key domains that might comprehensively characterize any external support intervention that could be used by both external groups or researchers and healthcare leaders

This webinar discusses substance use disorders (SUDs), including Opioid Use Disorder, as a disability and federal disability rights protections for individuals receiving MAT.

The National Center on Substance Abuse and Child Welfare (NCSACW), together with the Office for Civil Rights (OCR), created this training series to provide information to child welfare and court professionals about federal disability rights protections that apply to some parents with an opioid or other substance use disorder who are involved with child welfare.

This video offers an in-depth look at MAT while addressing common misconceptions about the treatment. It highlights strategies that inform effective child welfare and court practices and addresses common misconceptions.

This program — Support for Hospital Opioid Use Treatment (Project SHOUT) — provides clinical leaders with the tools they need to start and maintain patients on buprenorphine or methadone during hospitalizations for any condition, be it medical, surgical, or obstetric.

The ASAM Treatment of Opioid Use Disorder Course provides eight hours of required education to qualify for the waiver to prescribe buprenorphine in an office-based setting and covers essential information for providers to identify, assess, diagnose, and manage patients with opioid use disorder (OUD). The course covers the latest information on medications and treatments for OUD.

The U.S. Agency for Healthcare Research and Quality, on behalf of the U.S. Department of Health and Human Services, commissioned a rapid evidence review on the effectiveness of interventions to promote a broader understanding of the published literature on medication-assisted treatment retention among adults with opioid use disorder.

Provides an introduction to implementing telehealth services in primary care during COVID-19, including the prerequisites, policies, procedures, and practice